Call: (760) 810-4104
The FACTS on Regenerative Medicine vs. Surgery
Invasive or Non Invasive?
Have you been diagnosed with bone on bone knee osteoarthritis? Here are 2 of the major treatment options available. One is invasive and one non-invasive.
Regenerative Amniotic Membrane Tissue Treatment vs Surgery
|Downtime||None||3 to 6 months|
|Improvement 1 year||70%+||80%+|
|Cost||$4500||Up to $10,000 out of pocket|
|Procedure Time||15 - 20 Minutes||+ Hours|
|Pain Relief 3 Weeks||40%||0%|
|Side Effects||None||Infection, Embolism, Death|
Knee Replacement Cost: https://www.healthline.com/health/total-knee-replacement-surgery/understanding-costs#1
Surgenex no side effects statement: https://surgenexcatalog.com/images/brochure/Patient-Brochure.pdf
Chronic Knee Pain? Which Phase Are You?
Almost 10% of the United States population suffers from symptomatic knee osteoarthritis by the age of 60. Image A. shows a normal knee of a younger person. Note the spacing in the joint. Image D shows advanced degeneration of the knee which may require surgery.
As we age, our joints degenerate and so do the stem cells in our bodies which regenerate our cartilage, muscle and bone which can no longer keep the pace required to maintain a healthy joint.
Knee pain is often caused by wear and tear and activities such as golf, tennis or skiing. Your orthopedic physician/surgeon will often suggest invasive knee surgery to resolve chronic knee pain but it is important to know there is an alternative. Stem cell knee injections are fast becoming the answer to resolving acute and chronic knee pain as an alternative to knee replacement surgery.
Data Outcome Results on Knee Patients
Our study is complete and the data is in! Our patients have experienced an average of 53% improvement in mobility and pain relief after 12 weeks, 65% after 6 months and over 70%* after 1 year. Why risk invasive surgery - sign up for a free consultation to see if your a candidate.
Contact us at 760 810 4104 to learn more!
(Study data based on knee treatments. 1 year outcome is still under progress but early results are showing over 70% improvement in both mobility and pain relief! All results based on patient reported outcomes.)
All regenerative medicine procedures performed at StemX by Spark are performed using an Amniotic Tissue injection which is Regulated by the United States Food and Drug Administration as Human Cells, Tissues, Cellular and Tissue-Based Products (HCT/P's) under Section 361.decision.
This healthcare practitioner performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care physician prior to undergoing a regenerative therapy.